Product Information

BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $1.0315 per EA under NDC 70752014710. Its NADAC has been published 106 times since Nov 13, 2024.

FDA first approved this application on Feb 1, 2024. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB

BUTALBITAL and ACETAMINOPHEN
$1.0315per EA
DEA Schedule CIII

Strength

300; 50 mg/1; mg/1

NDC

70752014710

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ACETAMINOPHEN; BUTALBITAL

Approval Type

Generic (ANDA)

FDA Application

ANDA214305

FDA Approved

2/1/2024

TE Code

AA

On Market Since

5/1/2024

Pharmacological Classes

Barbiturate
Barbiturates

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB has been published 106 times since Nov 13, 2024, and over the history we have for it it has declined 67.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0315 per EA
All-time high$3.5911 (Dec 11, 2024)
All-time low$0.8746 (Sep 23, 2026)
52-week high$1.5543
52-week low$0.8746
Median price$1.5433
Average price$1.8558
Largest weekly change-42.9% (Sep 23, 2026)
Weeks tracked106
Tracking sinceNov 13, 2024

Price History

1W

+17.9%

1M

+17.9%

3M

-32.7%

6M

-32.7%

1Y

-33.6%

3Y

N/A

5Y

N/A

All

-67.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUTALBITAL and ACETAMINOPHEN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB, manufactured by Quagen Pharmaceuticals LLC, is $1.0315 per EA (NDC 70752014710), effective Nov 18, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB has declined 67.7%. It has been tracked across 106 weekly CMS publications since Nov 13, 2024.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?

Since Nov 13, 2024, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB has ranged from a low of $0.8746 (Sep 23, 2026) to a high of $3.5911 (Dec 11, 2024), with a median of $1.5433 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?

No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB?

BUTALBITAL-ACETAMINOPHEN 50-300 MG TAB (NDC 70752014710) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.